Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada. Watch the video here.
Is it because the only confirmed deal so far is with mologic to sell to 3rd world countries made by GAD. OdX will will lead the Gov test RNS which will probably say they are using Avactas tests. And BBI and Abingdon will have to wait till Avacta win their own clients and any left over requirement from UK gov. THU will be a lot of info but feels like Avacta are central to a lot of things. Todays RNS is just the foundation, many more layers to unfold.
Jd yes lots of potential. But its at 600m+ valuation. That's very expensive for a company which only has research products. We need a final product to justify this valuation, which is why we need this lft on sale. If it fails, we will be half this valuation before u can hit sell.
I haven't said they failed, I said it could fail. We just don't know. All i know is it's April 2021 and their is no approved product, no saliva, no BAMS, no LFT. LfT is the closest and all we have is 30 Spanish people saying it worked. I dont care what the reasons are because I used up those excuses in Q4. It's now Q2. Simple facts, to date they have failed to bring to market a working test after 12 months of the project. Dont care who is to blame, that is the simple FACT. I know all this can change just with one RNS which is why im holding on.
Regarding the company and my investment is linked, yes of course they are tied, but there are differences. As a shareholder I am disappointed with their communication to investors, failure to meet deadlines, failure to update when the deadlines have been missed. Another difference will be the numbers. The company could be happy to put affimers on the map but not make too much money from it, which will hit the valuation we are putting on the company (which is already a concern for some). A business focused on shareholder return would have already launched V1 of the test, generating shareholder value and derisking the V2. They have not. A good company doesnt always mean its a good investment (although I do believe/hope Avacta is one)
People don't like having alternative views on here, they just want to blindly promote Avacta like it's their baby. I dont care about the company all I care about is my investment. If you want to be paranoid and think any alternative debates means we have a hidden agenda, then so be it. Pathetic that you think people have nothing better to do than type rubbish on here to ruin other people's investments. I'm only here to understand whats going on better and to voice good or bad thoughts. I dont want to just hear people being optimistic, I want to hear both sides to the story and make a judgement based on all the info. I can assure you I wouldnt be wasting anytime on here if I wasn't invested.
Sang totally agree, waiting for AVA we could be well into 2030 based on their track record. It's all about the lft for me and I will keep some in for the long term, as I'm sure we will be a hot takeover target. Many will sell for £5 or £10 by summer and come back later for AVA I think.
Yes i saw the older news articles but thats just old news releases. Didn't notice that covid is under the drop down menu. Strange it isn't more visible on the homepage but atleast its still there under the menu.
I am still invested and still waiting for Q1, I mean near Q1, I mean Q2.